Parkman Healthcare Partners’s Accuray ARAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$343K Buy
884,578
+32,566
+4% +$20.1K 0.04% 89
2025
Q4
$703K Buy
+852,012
New +$1.06M 0.07% 94

Other funds holding ARAY

Parkman Healthcare Partners's ARAY Position: Q1 2026 in Review

Parkman Healthcare Partners increased its Accuray (ARAY) stake by 3.8% in Q1 2026, buying an estimated $20.1K and bringing the position to 884,578 shares worth $343K. The position accounts for 0.04% of the portfolio, ranked #89.

Parkman Healthcare Partners first reported a position in ARAY in Q4 2025 and has held it in 2 quarters since. The position peaked at $703K in Q4 2025. 125 funds tracked by Wall St. Rank hold ARAY as of Q1 2026.

  • Parkman Healthcare Partners held 884,578 shares of Accuray worth $343K as of Q1 2026.
  • Parkman Healthcare Partners bought 32,566 Accuray shares in Q1 2026, an estimated $20.1K.
  • Accuray made up 0.04% of Parkman Healthcare Partners's portfolio in Q1 2026, its #89 holding.
  • Parkman Healthcare Partners first reported a position in Accuray in Q4 2025 and has held it in 2 quarters since.
  • Parkman Healthcare Partners's Accuray position peaked at $703K in Q4 2025.
  • 125 funds tracked by Wall St. Rank held Accuray as of Q1 2026.

Based on Parkman Healthcare Partners's 13F filing for Q1 2026, filed 15 May 2026.